Financials
- Market Capitalization 48.52 M
- Employee 8
- Founded 2018
- CEO N/A
- Website www.impactbiomedinc.com
- Headquarter Nevada, United States
- FIGI BBG01JFZG014
- Industry 医薬品メーカー(一般)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-1.33
売上高対価格比率
995.81
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4085 | OSTX OS Therapies Incorporated Common Stock | 1.64 USD | -2.38% | +9.33% | +10.07% | +42.61% | 75.65 M USD | ||
| 4148 | EXOZ eXoZymes Inc. - Common Stock | 7.17 USD | -0.14% | +8.31% | +52.55% | -26.08% | 66.55 M USD | ||
| 4290 | SCLX Scilex Holding Company - Common Stock | 5.43 USD | -2.51% | -6.22% | -17.23% | -33.21% | 46.12 M USD | ||
| 4443 | MIRA MIRA Pharmaceuticals, Inc. - Common Stock | 0.75 USD | -2.60% | -3.85% | -11.76% | -45.26% | 31.52 M USD |